Arianne Phosphate Inc.
DRRSF
$0.095
-$0.001-1.04%
| Weiss Ratings | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.26 | |||
| Price History | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.85% | |||
| 30-Day Total Return | -11.22% | |||
| 60-Day Total Return | -19.70% | |||
| 90-Day Total Return | -29.79% | |||
| Year to Date Total Return | -5.57% | |||
| 1-Year Total Return | -54.76% | |||
| 2-Year Total Return | -69.32% | |||
| 3-Year Total Return | -81.64% | |||
| 5-Year Total Return | -49.47% | |||
| 52-Week High % Change | -61.29% | |||
| 52-Week Low % Change | 15.66% | |||
| Price | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.25 | |||
| 52-Week Low Price | $0.08 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Mar 13, 2024 | |||
| Valuation | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 19.57M | |||
| Enterprise Value | 38.60M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | 5.80% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.82 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.10 | |||
| Enterprise Value/EBITDA (TTM) | -21.63 | |||
| Enterprise Value/EBIT | -21.15 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 202.89M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 418 549 7316 | |||
| Address | 901 Boulevard Talbot Chicoutimi, QC G7H 6N7 | |||
| Website | www.arianne-inc.com | |||
| Country | Canada | |||
| Year Founded | 1997 | |||
| Profitability | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -2.33% | |||
| Return on Equity | -- | |||
| Income Statement | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -490.10K | |||
| EBITDA (TTM) | -1.78M | |||
| EBIT (TTM) | -1.83M | |||
| Net Income (TTM) | -4.42M | |||
| Net Income Avl. to Common (TTM) | -4.42M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -9.29% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | -6.32% | |||
| Balance Sheet | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.06M | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 1.25M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 23.65M | |||
| Current Ratio (Q) | 0.752 | |||
| Book Value Per Share (Q) | $0.12 | |||
| Total Assets (Q) | 48.13M | |||
| Total Current Liabilities (Q) | 1.67M | |||
| Total Debt (Q) | 21.51M | |||
| Total Liabilities (Q) | 24.49M | |||
| Total Common Equity (Q) | 23.65M | |||
| Cash Flow | DRRSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -62.50K | |||
| Cash from Financing (TTM) | -84.90K | |||
| Net Change in Cash (TTM) | -1.72M | |||
| Levered Free Cash Flow (TTM) | -3.87M | |||
| Cash from Operations (TTM) | -1.57M | |||
